{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:02:54Z","timestamp":1790532174551,"version":"4.1.0"},"reference-count":271,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.preteyeres.2018.10.006","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T21:48:05Z","timestamp":1540849685000},"page":"116-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"special_numbering":"C","title":["The role of placental growth factor (PlGF) and its receptor system in retinal vascular diseases"],"prefix":"10.1016","volume":"69","author":[{"given":"Tine","family":"Van Bergen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Etienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0186-1411","authenticated-orcid":false,"given":"Lieve","family":"Moons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinier O.","family":"Schlingemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean H.M.","family":"Feyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan W.","family":"Stitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preteyeres.2018.10.006_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00281-008-0111-x","article-title":"Immunological mechanisms in the pathogenesis of diabetic retinopathy","volume":"30","author":"Adamis","year":"2008","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib2","first-page":"2749","article-title":"Placental growth factor is a survival factor for tumor endothelial cells and macrophages","volume":"62","author":"Adini","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib3","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archopht.119.10.1439","article-title":"A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9","volume":"119","author":"Age-Related Eye Disease Study Research Group","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/bs.ctdb.2016.10.001","article-title":"VEGF receptor tyrosine kinases: key regulators of vascular function","volume":"123","author":"Alvarez-Aznar","year":"2017","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib5","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature05249","article-title":"Corneal avascularity is due to soluble VEGF receptor-1","volume":"443","author":"Ambati","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib6","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1111\/aos.12251","article-title":"Aqueous humour levels of placental growth factor in diabetic retinopathy","volume":"92","author":"Ando","year":"2014","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib7","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.2337\/db05-1635","article-title":"Diabetic retinopathy: seeing beyond glucose-induced microvascular disease","volume":"55","author":"Antonetti","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/bjo.2007.127142","article-title":"Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy","volume":"92","author":"Arevalo","year":"2008","journal-title":"Br. J. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3928\/23258160-20170301-06","article-title":"Short-term effects of early switching to ranibizumab or aflibercept in diabetic macular edema cases with non-response to bevacizumab","volume":"48","author":"Ashraf","year":"2017","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1517\/13543784.2013.794782","article-title":"Alprostadil infusion in patients with dry age related macular degeneration: a randomized controlled clinical trial","volume":"22","author":"Augustin","year":"2013","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib11","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nm884","article-title":"Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1","volume":"9","author":"Autiero","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-4615-0119-0_2","article-title":"Neuropilins as Semaphorin receptors: in vivo functions in neuronal cell migration and axon guidance","volume":"515","author":"Bagri","year":"2002","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cell.2010.01.033","article-title":"PlGF blockade does not inhibit angiogenesis during primary tumor growth","volume":"141","author":"Bais","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib14","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1042\/BST20110671","article-title":"An unexpected tail of VEGF and PlGF in pre-eclampsia","volume":"39","author":"Bates","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajo.2016.04.003","article-title":"Retinal ganglion cell layer change in patients treated with anti-vascular endothelial growth factor for neovascular age-related macular degeneration","volume":"167","author":"Beck","year":"2016","journal-title":"Am. J. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib16","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/sj.bjp.0706347","article-title":"Intracellular pathways triggered by the selective FLT-1-agonist placental growth factor in vascular smooth muscle cells exposed to hypoxia","volume":"146","author":"Bellik","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib17","first-page":"531","article-title":"Inhibition of placental growth factor in renal cell carcinoma","volume":"35","author":"Bessho","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0002-9440(10)65138-3","article-title":"Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation","volume":"155","author":"Blaauwgeers","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib19","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1165\/rcmb.2011-0152OC","article-title":"Placental growth factor contributes to bronchial neutrophilic inflammation and edema in allergic asthma","volume":"46","author":"Bobic","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib20","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/IAE.0000000000001392","article-title":"The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as therapeutic target","volume":"37","author":"Boyer","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib21","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/jcb.21579","article-title":"VEGF in biological control","volume":"102","author":"Breen","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ophtha.2008.10.018","article-title":"Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study","volume":"116","author":"Brown","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib23","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.ophtha.2013.02.034","article-title":"Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE","volume":"120","author":"Brown","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib24","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ophtha.2015.06.017","article-title":"Intravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studies","volume":"122","author":"Brown","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib25","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1007\/s13277-014-2892-y","article-title":"Inhibition of metastasis of oral squamous cell carcinoma by anti-PLGF treatment","volume":"36","author":"Bu","year":"2015","journal-title":"Tumour. Biol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib26","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00592-018-1151-x","article-title":"Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema","volume":"55","author":"Busch","year":"2018","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib27","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.2337\/diabetes.52.12.2959","article-title":"Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells","volume":"52","author":"Cai","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib28","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/ICU.0000000000000424","article-title":"Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema: recent clinically relevant findings from DRCR.net Protocol T","volume":"28","author":"Cai","year":"2017","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.preteyeres.2015.06.002","article-title":"Molecular pathogenesis of retinal and choroidal vascular diseases","volume":"49","author":"Campochiaro","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib30","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.ophtha.2011.02.038","article-title":"Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study","volume":"118","author":"Campochiaro","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib31","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ophtha.2014.08.031","article-title":"Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT study","volume":"122","author":"Campochiaro","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib32","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ophtha.2010.02.021","article-title":"Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study","volume":"117","author":"Campochiaro","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib33","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.1167\/iovs.09-4956","article-title":"A subretinal matrigel rat choroidal neovascularization (CNV) model and inhibition of CNV and associated inflammation and fibrosis by VEGF trap","volume":"51","author":"Cao","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib34","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1073\/pnas.0911661107","article-title":"VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy","volume":"107","author":"Cao","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib35","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1074\/jbc.271.6.3154","article-title":"Heterodimers of placenta growth factor\/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1\/KDR","volume":"271","author":"Cao","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib36","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1006\/bbrc.1997.6813","article-title":"Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing","volume":"235","author":"Cao","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib37","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","article-title":"Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions","volume":"7","author":"Carmeliet","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib38","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00018-005-5426-3","article-title":"The role of VEGF receptors in angiogenesis; complex partnerships","volume":"63","author":"Cebe-Suarez","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/glia.21108","article-title":"Involvement of placental growth factor in Wallerian degeneration","volume":"59","author":"Chaballe","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib40","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ophtha.2017.11.036","article-title":"Characterizing disease burden and progression of geographic atrophy secondary to age-related macular degeneration","volume":"125","author":"Chakravarthy","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib41","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/jhh.2017.61","article-title":"Placental growth factor and pre-eclampsia","volume":"31","author":"Chau","year":"2017","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1465-9921-10-115","article-title":"Prevention of elastase-induced emphysema in placenta growth factor knock-out mice","volume":"10","author":"Cheng","year":"2009","journal-title":"Respir. Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib43","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/thx.2007.087155","article-title":"Increased expression of placenta growth factor in COPD","volume":"63","author":"Cheng","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib44","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41433-018-0061-z","article-title":"Cellular regeneration strategies for macular degeneration: past, present and future","volume":"32","author":"Chichagova","year":"2018","journal-title":"Eye (Lond)."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib45","doi-asserted-by":"crossref","first-page":"10382","DOI":"10.1074\/jbc.M313237200","article-title":"The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1","volume":"279","author":"Christinger","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib46","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2353\/ajpath.2006.051314","article-title":"Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential","volume":"169","author":"Cianfarani","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib47","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000342848","article-title":"Intravitreal ranibizumab and laser photocoagulation in the management of idiopathic juxtafoveolar retinal telangiectasia type 1: a case report","volume":"3","author":"Ciarnella","year":"2012","journal-title":"Case Rep. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib48","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ophtha.2015.09.035","article-title":"Intravitreal aflibercept for macular edema following branch retinal vein occlusion: 52-week results of the VIBRANT study","volume":"123","author":"Clark","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib49","doi-asserted-by":"crossref","first-page":"17629","DOI":"10.1074\/jbc.271.30.17629","article-title":"The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis","volume":"271","author":"Clauss","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib50","doi-asserted-by":"crossref","first-page":"e1005445","DOI":"10.1371\/journal.pcbi.1005445","article-title":"A computational analysis of in vivo VEGFR activation by multiple co-expressed ligands","volume":"13","author":"Clegg","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib51","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ebiom.2016.11.016","article-title":"Phase 2a randomized clinical trial: safety and post hoc analysis of subretinal rAAV.sFLT-1 for wet age-related macular degeneration","volume":"14","author":"Constable","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib52","first-page":"908","article-title":"Anti-vascular endothelial growth factor acts on retinal microglia\/macrophage activation in a rat model of ocular inflammation","volume":"20","author":"Couturier","year":"2014","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib53","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1167\/iovs.16-21283","article-title":"Inhibition of placenta growth factor reduces subretinal mononuclear phagocyte accumulation in choroidal neovascularization","volume":"58","author":"Crespo-Garcia","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib54","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nbt.4114","article-title":"Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration","volume":"36","author":"Da Cruz","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib55","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ophtha.2013.10.019","article-title":"Risk of scar in the comparison of age-related macular degeneration treatments trials","volume":"121","author":"Daniel","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib56","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.1312256","article-title":"The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor","volume":"255","author":"de Vries","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib57","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.exer.2013.07.018","article-title":"VEGF but not PlGF disturbs the barrier of retinal endothelial cells","volume":"115","author":"Deissler","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib58","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1167\/iovs.15-18598","article-title":"Neuropilin-1-Expressing microglia are associated with nascent retinal vasculature yet dispensable for developmental angiogenesis","volume":"57","author":"Dejda","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib59","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011056","article-title":"PlGF: a multitasking cytokine with disease-restricted activity","volume":"2","author":"Dewerchin","year":"2012","journal-title":"Cold Spring Harb.Perspect.Med."},{"issue":"1","key":"10.1016\/j.preteyeres.2018.10.006_bib271","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s003359900003","article-title":"The placenta growth factor gene of the mouse","volume":"7","author":"DiPalma","year":"1996","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib60","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.drudis.2012.11.013","article-title":"Targeting VEGF signalling via the neuropilin co-receptor","volume":"18","author":"Djordjevic","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib61","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/bjo.2008.138271","article-title":"An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedema","volume":"93","author":"Do","year":"2009","journal-title":"Br. J. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib62","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.ophtha.2011.02.018","article-title":"The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema","volume":"118","author":"Do","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051378","article-title":"Polarised VEGFA signalling at vascular blood-neural barriers","volume":"19","author":"Dragoni","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib64","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/s41467-017-01738-3","article-title":"Pericytes regulate VEGF-induced endothelial sprouting through VEGFR1","volume":"8","author":"Eilken","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib65","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.neuron.2011.02.052","article-title":"VEGF signaling through neuropilin 1 guides commissural axon crossing at the optic chiasm","volume":"70","author":"Erskine","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib66","first-page":"CD000254","article-title":"Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration","volume":"7","author":"Evans","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051306","article-title":"Positive and negative regulation of angiogenesis by soluble vascular endothelial growth factor receptor-1","volume":"19","author":"Failla","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib68","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1167\/iovs.02-0040","article-title":"Role of vascular endothelial growth factor and placental growth factors during retinal vascular development and hyaloid regression","volume":"44","author":"Feeney","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib69","article-title":"A clinico-pathological study of the structural and functional changes to the retina and optic nerve following anti-VEGF treatments for diabetic macular edema","volume":"58","author":"Filek","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib70","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cell.2007.08.038","article-title":"Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels","volume":"131","author":"Fischer","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib71","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/376066a0","article-title":"Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium","volume":"376","author":"Fong","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib72","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1172\/JCI31030","article-title":"Fibrosis and diseases of the eye","volume":"117","author":"Friedlander","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib73","doi-asserted-by":"crossref","first-page":"26690","DOI":"10.1016\/S0021-9258(19)61431-6","article-title":"The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1","volume":"275","author":"Fuh","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib74","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00417-008-0795-6","article-title":"Bevacizumab in the treatment of idiopathic macular telangiectasia","volume":"246","author":"Gamulescu","year":"2008","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib75","doi-asserted-by":"crossref","first-page":"23659","DOI":"10.1074\/jbc.272.38.23659","article-title":"Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1\/KDR, is up-regulated by hypoxia","volume":"272","author":"Gerber","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib76","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/dvdy.20148","article-title":"Neuropilin-1 is required for endothelial tip cell guidance in the developing central nervous system","volume":"231","author":"Gerhardt","year":"2004","journal-title":"Dev.Dyn."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib77","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1074\/jbc.M002016200","article-title":"Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants","volume":"276","author":"Gille","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib78","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.ophtha.2015.05.010","article-title":"Long-term outcomes of treatment of neovascular age-related macular degeneration: data from an observational study","volume":"122","author":"Gillies","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib79","first-page":"2696","article-title":"Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1","volume":"61","author":"Green","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib80","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.preteyeres.2008.05.002","article-title":"The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration","volume":"27","author":"Grisanti","year":"2008","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib81","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2337\/diabetes.47.3.401","article-title":"Upregulation of the vascular endothelial growth factor\/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat","volume":"47","author":"Hammes","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib82","doi-asserted-by":"crossref","first-page":"605946","DOI":"10.1155\/2015\/605946","article-title":"Blockade of vascular endothelial growth factor receptor 1 prevents inflammation and vascular leakage in diabetic retinopathy","volume":"2015","author":"He","year":"2015","journal-title":"J. Ophthalmol"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib83","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib84","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.ophtha.2014.01.027","article-title":"Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS study","volume":"121","author":"Heier","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib85","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/MEG.0b013e3283554219","article-title":"Inhibition of the placental growth factor decreases burden of cholangiocarcinoma and hepatocellular carcinoma in a transgenic mouse model","volume":"24","author":"Heindryckx","year":"2012","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib86","doi-asserted-by":"crossref","first-page":"9349","DOI":"10.1073\/pnas.95.16.9349","article-title":"Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice","volume":"95","author":"Hiratsuka","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib87","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s00417-005-0154-9","article-title":"Human retinal epithelium produces and responds to placenta growth factor","volume":"244","author":"Hollborn","year":"2006","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"6","key":"10.1016\/j.preteyeres.2018.10.006_bib88","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamaophthalmol.2018.1544","article-title":"Efficacy and safety of Lampalizumab for geographic atrophy due to age-related macular degeneration: chroma and spectri phase 3 randomized clinical trials","volume":"136","author":"Holz","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib89","doi-asserted-by":"crossref","first-page":"18316","DOI":"10.1038\/srep18316","article-title":"Sustained intraocular VEGF neutralization results in retinal neurodegeneration in the Ins2(Akita) diabetic mouse","volume":"5","author":"Hombrebueno","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib90","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12931-014-0106-1","article-title":"PlGF mediates neutrophil elastase-induced airway epithelial cell apoptosis and emphysema","volume":"15","author":"Hou","year":"2014","journal-title":"Respir. Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib91","series-title":"Targeting Placental Growth Factor Attenuates Retinal Permeability and Inflammation in Diabetic Akimba Mice","author":"Hu","year":"2017"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib92","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2337\/db14-0016","article-title":"Deletion of placental growth factor prevents diabetic retinopathy and is associated with Akt activation and HIF1alpha-VEGF pathway inhibition","volume":"64","author":"Huang","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib93","doi-asserted-by":"crossref","first-page":"e71808","DOI":"10.1371\/journal.pone.0071808","article-title":"VEGF receptor blockade markedly reduces retinal microglia\/macrophage infiltration into laser-induced CNV","volume":"8","author":"Huang","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib94","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.devcel.2014.06.027","article-title":"Differential apicobasal VEGF signaling at vascular blood-neural barriers","volume":"30","author":"Hudson","year":"2014","journal-title":"Dev. Cell"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib95","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1159\/000373990","article-title":"Inhibition of ocular neovascularization by co-inhibition of VEGF-A and PLGF","volume":"35","author":"Huo","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib96","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/jnr.23316","article-title":"Protective effects of placental growth factor on retinal neuronal cell damage","volume":"92","author":"Inoue","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib97","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00417-017-3846-z","article-title":"Plasma levels of hypoxia-regulated factors in patients with age-related macular degeneration","volume":"256","author":"Ioanna","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib98","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/jcp.1121","article-title":"Expression of vascular endothelial growth factor receptors in smooth muscle cells","volume":"188","author":"Ishida","year":"2001","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib99","first-page":"1649","article-title":"Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy","volume":"41","author":"Ishida","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib100","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1167\/iovs.02-0807","article-title":"VEGF164 is proinflammatory in the diabetic retina","volume":"44","author":"Ishida","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib101","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1084\/jem.20022027","article-title":"VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization","volume":"198","author":"Ishida","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib102","first-page":"1172","article-title":"Colocalization of neuropilin-1 and Flk-1 in retinal neovascularization in a mouse model of retinopathy","volume":"42","author":"Ishihama","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib103","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000479937","article-title":"Two-year outcomes of a treat-and-extend regimen using intravitreal aflibercept injections for typical age-related macular degeneration","volume":"238","author":"Ito","year":"2017","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib104","doi-asserted-by":"crossref","first-page":"12153","DOI":"10.1074\/jbc.M008055200","article-title":"The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution","volume":"276","author":"Iyer","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib105","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1167\/iovs.15-16748","article-title":"Protective effects of antiplacental growth factor Antibody against light-induced retinal damage in mice","volume":"56","author":"Izawa","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib106","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10456-013-9381-6","article-title":"Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo","volume":"17","author":"Jetten","year":"2014","journal-title":"Angiogenesis"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib107","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1097\/IAE.0b013e3182576d07","article-title":"Cytokine concentration in aqueous humor of eyes with diabetic macular edema","volume":"32","author":"Jonas","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib108","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1096\/fj.03-1476fje","article-title":"A central role for inflammation in the pathogenesis of diabetic retinopathy","volume":"18","author":"Joussen","year":"2004","journal-title":"Faseb. J."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib109","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5301\/ejo.5000838","article-title":"Ranibizumab for persistent diabetic macular edema after bevacizumab treatment","volume":"27","author":"Katz","year":"2017","journal-title":"Eur. J. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib110","doi-asserted-by":"crossref","first-page":"7484","DOI":"10.1167\/iovs.12-9970","article-title":"Two-year intraocular delivery of ciliary neurotrophic factor by encapsulated cell technology implants in patients with chronic retinal degenerative diseases","volume":"53","author":"Kauper","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib111","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/bbrc.1996.1355","article-title":"Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR","volume":"226","author":"Kendall","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib112","first-page":"109","article-title":"Increased expression of placenta growth factor in proliferative diabetic retinopathy","volume":"78","author":"Khaliq","year":"1998","journal-title":"Lab. Invest."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib113","first-page":"2115","article-title":"Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes","volume":"40","author":"Kim","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib114","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3858\/emm.2012.44.1.023","article-title":"Role of placenta growth factor in cancer and inflammation","volume":"44","author":"Kim","year":"2012","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib115","doi-asserted-by":"crossref","first-page":"e0187304","DOI":"10.1371\/journal.pone.0187304","article-title":"Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fibrovascular membranes","volume":"12","author":"Klaassen","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib116","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.exer.2014.10.016","article-title":"The role of CTGF in diabetic retinopathy","volume":"133","author":"Klaassen","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib117","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.preteyeres.2013.02.001","article-title":"Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions","volume":"34","author":"Klaassen","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib118","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40942-017-0064-0","article-title":"Effect of intravitreal aflibercept on recalcitrant diabetic macular edema","volume":"3","author":"Klein","year":"2017","journal-title":"Int. J. Retina Vitreous."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib119","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/eye.2011.252","article-title":"Bevacizumab and type 1 idiopathic macular telangiectasia","volume":"25","author":"Koay","year":"2011","journal-title":"Eye (Lond)."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib120","doi-asserted-by":"crossref","first-page":"8289253","DOI":"10.1155\/2018\/8289253","article-title":"Pharmacological management of diabetic macular edema in real-life observational studies","volume":"2018","author":"Kodjikian","year":"2018","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib121","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.ophtha.2014.05.006","article-title":"Intravitreal aflibercept for diabetic macular edema","volume":"121","author":"Korobelnik","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib122","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3928\/23258160-20160601-14","article-title":"Macular telangiectasia type 1 managed with long-term aflibercept therapy","volume":"47","author":"Kovach","year":"2016","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib123","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1167\/iovs.15-16793","article-title":"Angiogenic and inflammatory vitreous biomarkers associated with increasing levels of retinal ischemia","volume":"56","author":"Kovacs","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib124","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1097\/IAE.0000000000001424","article-title":"Efficacy of intravitreal aflibercept in macular telangiectasia type 1 is linked to the ocular angiogenic profile","volume":"37","author":"Kowalczuk","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib125","doi-asserted-by":"crossref","first-page":"e17462","DOI":"10.1371\/journal.pone.0017462","article-title":"Placental growth factor contributes to micro-vascular abnormalization and blood-retinal barrier breakdown in diabetic retinopathy","volume":"6","author":"Kowalczuk","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib126","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/01.iae.0000434565.80060.f8","article-title":"Phase 1, dose-ranging study of emixustat hydrochloride (ACU-4429), a novel visual cycle modulator, in healthy volunteers","volume":"34","author":"Kubota","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib127","doi-asserted-by":"crossref","first-page":"e2675","DOI":"10.1371\/journal.pone.0002675","article-title":"The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy","volume":"3","author":"Kuiper","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib128","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12935-018-0530-2","article-title":"Crosstalk between VEGFR and other receptor tyrosine kinases for TKI therapy of metastatic renal cell carcinoma","volume":"18","author":"Lai","year":"2018","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00417-017-3836-1","article-title":"Aflibercept in diabetic macular edema refractory to previous bevacizumab: outcomes and predictors of success","volume":"256","author":"Laiginhas","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.preteyeres.2016.04.003","article-title":"Risk factors and biomarkers of age-related macular degeneration","volume":"54","author":"Lambert","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib131","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/eye.2011.92","article-title":"The burden of disease of retinal vein occlusion: review of the literature","volume":"25","author":"Laouri","year":"2011","journal-title":"Eye (Lond)."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib132","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/mc.10126","article-title":"Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angiopoietin expression in mouse skin carcinogenesis","volume":"37","author":"Larcher","year":"2003","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib133","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/bjc.2011.609","article-title":"A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours","volume":"106","author":"Lassen","year":"2012","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib134","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1089\/jop.2016.0074","article-title":"Short-term outcomes of switching to ranibizumab therapy for diabetic macular edema in patients with persistent fluid after bevacizumab therapy","volume":"32","author":"Lee","year":"2016","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40662-015-0026-2","article-title":"Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss","volume":"2","author":"Lee","year":"2015","journal-title":"Eye Vis.(Lond)."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib136","first-page":"1202","article-title":"Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab","volume":"8","author":"Li","year":"2015","journal-title":"Int. J. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib137","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1442-9071.2000.00222.x","article-title":"Retinal neurodegeneration: early pathology in diabetes","volume":"28","author":"Lieth","year":"2000","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib138","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ajo.2005.07.021","article-title":"Neuropilin-1 expression by endothelial cells and retinal pigment epithelial cells in choroidal neovascular membranes","volume":"140","author":"Lim","year":"2005","journal-title":"Am. J. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib139","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1128\/MCB.23.15.5269-5281.2003","article-title":"Human T-lymphotropic virus type 1 oncoprotein tax promotes unscheduled degradation of Pds1p\/securin and Clb2p\/cyclin B1 and causes chromosomal instability","volume":"23","author":"Liu","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib140","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1167\/iovs.12-11291","article-title":"Hyperoxia causes regression of vitreous neovascularization by downregulating VEGF\/VEGFR2 pathway","volume":"54","author":"Liu","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib141","first-page":"231913","article-title":"Macular oedema related to idiopathic macular telangiectasia type 1 treated with dexamethasone intravitreal implant (ozurdex)","volume":"2014","author":"Loutfi","year":"2014","journal-title":"Case. Rep. Ophthalmol. Med."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib142","first-page":"1808","article-title":"VEGF increases retinal vascular ICAM-1 expression in vivo","volume":"40","author":"Lu","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib143","doi-asserted-by":"crossref","first-page":"e00324","DOI":"10.7554\/eLife.00324","article-title":"Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1","volume":"2","author":"Luo","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib144","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nm731","article-title":"Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1","volume":"8","author":"Luttun","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib145","doi-asserted-by":"crossref","first-page":"9267","DOI":"10.1073\/pnas.88.20.9267","article-title":"Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor","volume":"88","author":"Maglione","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib146","first-page":"925","article-title":"Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14","volume":"8","author":"Maglione","year":"1993","journal-title":"Oncogene"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib147","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/HYPERTENSIONAHA.116.07286","article-title":"Placental growth factor reduces blood pressure in a uteroplacental ischemia model of preeclampsia in nonhuman primates","volume":"67","author":"Makris","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib148","article-title":"MACULAR ATROPHY INCIDENCE IN ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR-TREATED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: risk factor evaluation for individualized treatment need of ranibizumab or aflibercept according to an observe-and-plan regimen","author":"Mantel","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib149","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib150","series-title":"Age-related Macular Degeneration - Etiology, Diagnosis and Management - a Glance at the Future","first-page":"39","article-title":"Cigarette smoking and hypertension two risk factors for age- related macular degeneration","author":"Marin-Castano","year":"2013"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib151","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0002-9440(10)61231-X","article-title":"Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function","volume":"167","author":"Marneros","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib152","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00417-003-0838-y","article-title":"Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium","volume":"242","author":"Martin","year":"2004","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib153","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.clinthera.2011.08.007","article-title":"Monoclonal antibody TB-403: a first-in-human, Phase I, double-blind, dose escalation study directed against placental growth factor in healthy male subjects","volume":"33","author":"Martinsson-Niskanen","year":"2011","journal-title":"Clin.Ther."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib154","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2337\/dc10-0493","article-title":"Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study","volume":"33","author":"Massin","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib155","first-page":"320","article-title":"Intravitreal bevacizumab therapy for idiopathic macular telangiectasia","volume":"54","author":"Matsumoto","year":"2010","journal-title":"Jpn. J. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib156","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.preteyeres.2017.12.002","article-title":"Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors","volume":"65","author":"Mehta","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib157","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cytogfr.2017.11.005","article-title":"Vascular endothelial growth factors and placenta growth factor in retinal vasculopathies: current research and future perspectives","volume":"39","author":"Mesquita","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib158","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1096\/fj.00-0250com","article-title":"Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression","volume":"14","author":"Miao","year":"2000","journal-title":"Faseb. J."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib159","doi-asserted-by":"crossref","first-page":"5632634","DOI":"10.1155\/2017\/5632634","article-title":"Switch to aflibercept in diabetic macular edema patients unresponsive to previous anti-VEGF therapy","volume":"2017","author":"Mira","year":"2017","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib160","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.2337\/diacare.25.12.2352","article-title":"Vitreous levels of placenta growth factor and vascular endothelial growth factor in patients with proliferative diabetic retinopathy","volume":"25","author":"Mitamura","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib161","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ophtha.2011.01.031","article-title":"The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema","volume":"118","author":"Mitchell","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib162","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0002-9440(10)65044-4","article-title":"Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1)","volume":"156","author":"Miyamoto","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib163","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00125-006-0539-2","article-title":"Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy","volume":"50","author":"Miyamoto","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib164","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000119877","article-title":"PlGF-1 and VEGFR-1 pathway regulation of the external epithelial hemato-ocular barrier. A model for retinal edema","volume":"40","author":"Miyamoto","year":"2008","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib165","first-page":"1","article-title":"Intravitreal bevacizumab for macular edema from idiopathic retinal vasculitis, aneurysms, and neuroretinitis","author":"Moon","year":"2010","journal-title":"Ophthalmic Surg. Laser. Imag."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib166","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00417-008-0914-4","article-title":"Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy","volume":"246","author":"Moradian","year":"2008","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib167","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000478705","article-title":"Dynamics of inflammatory factors in aqueous humor during ranibizumab or aflibercept treatment for age-related macular degeneration","volume":"58","author":"Motohashi","year":"2017","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib168","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1167\/iovs.11-9119","article-title":"Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis","volume":"53","author":"Nakao","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib169","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1167\/iovs.12-11572","article-title":"Disruption of cell-cell junctions and induction of pathological cytokines in the retinal pigment epithelium of light-exposed mice","volume":"54","author":"Narimatsu","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib170","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","article-title":"Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE","volume":"119","author":"Nguyen","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib171","article-title":"Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases","author":"Nguyen","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib172","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/aos.13325","article-title":"Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases","volume":"96","author":"Nguyen","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib173","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.ophtha.2010.08.016","article-title":"Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study","volume":"117","author":"Nguyen","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib174","doi-asserted-by":"crossref","first-page":"e19873","DOI":"10.1371\/journal.pone.0019873","article-title":"Vascular endothelial growth factor in the circulation in cancer patients may not be a relevant biomarker","volume":"6","author":"Niers","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib175","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000475603","article-title":"Aqueous humor levels of soluble vascular endothelial growth factor receptor and inflammatory factors in diabetic macular edema","volume":"238","author":"Noma","year":"2017","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib176","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1167\/iovs.14-13961","article-title":"Role of soluble vascular endothelial growth factor receptors-1 and -2, their ligands, and other factors in branch retinal vein occlusion with macular edema","volume":"55","author":"Noma","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib177","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1167\/iovs.14-15789","article-title":"Role of soluble vascular endothelial growth factor receptor signaling and other factors or cytokines in central retinal vein occlusion with macular edema","volume":"56","author":"Noma","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib178","first-page":"4","article-title":"Knockdown of the placental growth factor gene inhibits laser induced choroidal neovascularization in a murine model","volume":"8","author":"Nourinia","year":"2013","journal-title":"J. Ophthalmic Vis. Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib179","doi-asserted-by":"crossref","first-page":"e90905","DOI":"10.1172\/jci.insight.90905","article-title":"Sustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdown","volume":"2","author":"Ogura","year":"2017","journal-title":"JCI. Insight."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib180","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ajo.2014.07.027","article-title":"Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study","volume":"158","author":"Ogura","year":"2014","journal-title":"Am. J. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib181","first-page":"281","article-title":"Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization","volume":"151","author":"Okamoto","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib182","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12886-015-0021-3","article-title":"Full thickness macular hole case after intravitreal aflibercept treatment","volume":"15","author":"Oshima","year":"2015","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib183","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3892\/ijo.2016.3362","article-title":"Placenta growth factor and neuropilin-1 collaborate in promoting melanoma aggressiveness","volume":"48","author":"Pagani","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.preteyeres.2018.10.006_bib184","first-page":"29","article-title":"Intravitreal aflibercept (A-IVI) for the treatment of neovascular age-related macular degeneration (nv-AMD): one year experience","volume":"18","author":"Papavasileiou","year":"2015","journal-title":"Hell. J. Nucl. Med."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib185","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.ajpath.2014.02.016","article-title":"Neuronal cell death in the inner retina and the influence of vascular endothelial growth factor inhibition in a diabetic rat model","volume":"184","author":"Park","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib186","doi-asserted-by":"crossref","first-page":"25646","DOI":"10.1016\/S0021-9258(18)47298-5","article-title":"Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1\/KDR","volume":"269","author":"Park","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib187","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1006\/bbrc.1999.1580","article-title":"The fourth immunoglobulin-like loop in the extracellular domain of FLT-1, a VEGF receptor, includes a major heparin-binding site","volume":"264","author":"Park","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib188","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041264","article-title":"Molecular pharmacology of VEGF-A isoforms: binding and signalling at VEGFR2","volume":"19","author":"Peach","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib189","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.preteyeres.2008.05.001","article-title":"Vascular endothelial growth factor in eye disease","volume":"27","author":"Penn","year":"2008","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib190","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1182\/blood-2002-11-3422","article-title":"Placenta growth factor activates monocytes and correlates with sickle cell disease severity","volume":"102","author":"Perelman","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib191","first-page":"31","article-title":"Structure, expression and receptor-binding properties of placenta growth factor (PlGF)","volume":"237","author":"Persico","year":"1999","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib192","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.2147\/OPTH.S171636","article-title":"Neovascular age-related macular degeneration: intraocular inflammatory cytokines in the poor responder to ranibizumab treatment","volume":"12","author":"Pongsachareonnont","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(17)30358-6","article-title":"Placental growth factor inhibition targets pulmonary angiogenesis and represents a novel therapy for hepatopulmonary syndrome in mice","author":"Raevens","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib194","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.preteyeres.2016.02.003","article-title":"NRP1 function and targeting in neurovascular development and eye disease","volume":"52","author":"Raimondi","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib195","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1167\/iovs.02-1092","article-title":"Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization","volume":"44","author":"Rakic","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib196","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.2353\/ajpath.2010.090883","article-title":"Characterization of a mouse model of hyperglycemia and retinal neovascularization","volume":"177","author":"Rakoczy","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib197","first-page":"52","article-title":"Diabetic retinopathy and inflammation: novel therapeutic targets. Middle East Afr","volume":"19","author":"Rangasamy","year":"2012","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib198","first-page":"70","article-title":"Management of macular edema due to central retinal vein occlusion - the role of aflibercept. Taiwan","volume":"7","author":"Rhoades","year":"2017","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib199","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10456-008-9114-4","article-title":"The discovery of the placental growth factor and its role in angiogenesis: a historical review","volume":"11","author":"Ribatti","year":"2008","journal-title":"Angiogenesis"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib200","doi-asserted-by":"crossref","first-page":"3940241","DOI":"10.1155\/2017\/3940241","article-title":"Ischemic retinopathies: oxidative stress and inflammation","volume":"2017","author":"Rivera","year":"2017","journal-title":"Oxid. Med. Cell Longev"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib201","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1242\/jcs.114.5.853","article-title":"The splice variants of vascular endothelial growth factor (VEGF) and their receptors","volume":"114","author":"Robinson","year":"2001","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib202","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ophtha.2018.02.027","article-title":"Preventing the growth of geographic atrophy: an important therapeutic target in age-related macular degeneration","volume":"125","author":"Rosenfeld","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib203","first-page":"361","article-title":"Ranibizumab: phase III clinical trial results","volume":"19","author":"Rosenfeld","year":"2006","journal-title":"Ophthalmol.Clin.North Am."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib204","first-page":"1357","article-title":"Twelve months of follow-up after intravitreal injection of ranibizumab for the treatment of idiopathic parafoveal telangiectasia","volume":"7","author":"Rouvas","year":"2013","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib205","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/j.febslet.2006.03.087","article-title":"Biology of vascular endothelial growth factors","volume":"580","author":"Roy","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib206","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jcp.10246","article-title":"VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier","volume":"195","author":"Saishin","year":"2003","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib207","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3928\/23258160-20150101-16","article-title":"Retinal pigment epithelial tear after intravitreal aflibercept for neovascular age-related macular degeneration","volume":"46","author":"Sato","year":"2015","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib208","first-page":"213","article-title":"Flt-1 but not KDR\/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor","volume":"7","author":"Sawano","year":"1996","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib209","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.ophtha.2011.01.043","article-title":"A systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy","volume":"118","author":"Sayegh","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00417-003-0828-0","article-title":"Role of growth factors and the wound healing response in age-related macular degeneration","volume":"242","author":"Schlingemann","year":"2004","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib211","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2337\/dc12-1951","article-title":"VEGF levels in plasma in relation to platelet activation, glycemic control, and microvascular complications in type 1 diabetes","volume":"36","author":"Schlingemann","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib212","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ophtha.2013.08.011","article-title":"Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies","volume":"121","author":"Schmidt-Erfurth","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib213","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10585-012-9477-1","article-title":"VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma","volume":"29","author":"Schultze","year":"2012","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib214","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2002-11-3423","article-title":"Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor","volume":"102","author":"Selvaraj","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib215","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2119\/2004-00017.Campochiaro","article-title":"Deficiency of neuropilin 2 suppresses VEGF-induced retinal neovascularization","volume":"10","author":"Shen","year":"2004","journal-title":"Mol. Med."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib216","first-page":"219792","article-title":"Macular oedema in idiopathic macular telangiectasia type 1 responsive to aflibercept but not bevacizumab","volume":"2014","author":"Shibeeb","year":"2014","journal-title":"Case. Rep. Ophthalmol. Med."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib217","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1357-2725(01)00026-7","article-title":"Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1)","volume":"33","author":"Shibuya","year":"2001","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib218","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1177\/1947601911423031","article-title":"Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies","volume":"2","author":"Shibuya","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib219","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.yexcr.2005.11.012","article-title":"Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis","volume":"312","author":"Shibuya","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib220","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1172\/JCI17808","article-title":"Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity","volume":"112","author":"Shih","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib221","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrm.2016.87","article-title":"Mechanisms and regulation of endothelial VEGF receptor signalling","volume":"17","author":"Simons","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib222","doi-asserted-by":"crossref","first-page":"e72755","DOI":"10.1371\/journal.pone.0072755","article-title":"Structural and functional measures of efficacy in response to bevacizumab monotherapy in diabetic macular oedema: exploratory analyses of the BOLT study (report 4)","volume":"8","author":"Sivaprasad","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib223","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/bjo.83.4.486","article-title":"Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy","volume":"83","author":"Smith","year":"1999","journal-title":"Br. J. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib224","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.cell.2013.01.036","article-title":"Targeting placental growth factor\/neuropilin 1 pathway inhibits growth and spread of medulloblastoma","volume":"152","author":"Snuderl","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib225","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1001\/archophthalmol.2012.1611","article-title":"Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1","volume":"130","author":"Sohn","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib226","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ajo.2011.03.033","article-title":"Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema","volume":"152","author":"Sohn","year":"2011","journal-title":"Am. J. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib227","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0092-8674(00)81402-6","article-title":"Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor","volume":"92","author":"Soker","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib228","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1076\/ceyr.18.6.490.5267","article-title":"Basement membrane and growth factor gene expression in normal and diabetic human retinas","volume":"18","author":"Spirin","year":"1999","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib229","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/HYPERTENSIONAHA.115.06783","article-title":"Placental growth factor Administration abolishes placental ischemia-induced hypertension","volume":"67","author":"Spradley","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib230","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.08.001","article-title":"The progress in understanding and treatment of diabetic retinopathy","volume":"51","author":"Stitt","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib231","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1172\/JCI20682","article-title":"VEGF: a critical player in neurodegeneration","volume":"113","author":"Storkebaum","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib232","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/bies.20092","article-title":"VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection","volume":"26","author":"Storkebaum","year":"2004","journal-title":"Bioessays"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib233","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/HYPERTENSIONAHA.109.134668","article-title":"Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice","volume":"54","author":"Suzuki","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib234","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2337\/diab.45.8.1016","article-title":"Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes","volume":"45","author":"Takagi","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib235","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/eye.2010.61","article-title":"Intravitreal bevacizumab for type 1 idiopathic macular telangiectasia","volume":"24","author":"Takayama","year":"2010","journal-title":"Eye (Lond)."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib236","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1006\/mvre.2002.2443","article-title":"Notch activation during endothelial cell network formation in vitro targets the basic HLH transcription factor HESR-1 and downregulates VEGFR-2\/KDR expression","volume":"64","author":"Taylor","year":"2002","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib237","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/0006-291X(92)90483-2","article-title":"Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor","volume":"187","author":"Terman","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib238","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00441-003-0776-3","article-title":"VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis","volume":"314","author":"Tjwa","year":"2003","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib239","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1164\/rccm.200306-774OC","article-title":"Overexpression of placenta growth factor contributes to the pathogenesis of pulmonary emphysema","volume":"169","author":"Tsao","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib240","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1167\/iovs.03-0106","article-title":"VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2","volume":"45","author":"Usui","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib241","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.exer.2017.09.012","article-title":"Neutralization of placental growth factor as a novel treatment option in diabetic retinopathy","volume":"165","author":"Van Bergen","year":"2017","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib242","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1111\/jcmm.12151","article-title":"Inhibition of placental growth factor improves surgical outcome of glaucoma surgery","volume":"17","author":"Van Bergen","year":"2013","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib243","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cell.2010.02.039","article-title":"Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease","volume":"141","author":"Van de Veire","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib244","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/bjophthalmol-2011-301005","article-title":"A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy","volume":"96","author":"van Geest","year":"2012","journal-title":"Br. J. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib245","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12885-015-1990-6","article-title":"Placental growth factor inhibition modulates the interplay between hypoxia and unfolded protein response in hepatocellular carcinoma","volume":"16","author":"Vandewynckel","year":"2016","journal-title":"BMC Canc."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib246","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1210\/en.2005-0532","article-title":"Modulation of angiogenesis during adipose tissue development in murine models of obesity","volume":"146","author":"Voros","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib247","doi-asserted-by":"crossref","first-page":"26988","DOI":"10.1016\/S0021-9258(18)47116-5","article-title":"Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor","volume":"269","author":"Waltenberger","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib248","doi-asserted-by":"crossref","first-page":"e10329","DOI":"10.1371\/journal.pone.0010329","article-title":"Abundant lipid and protein components of drusen","volume":"5","author":"Wang","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib249","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ajog.2012.05.003","article-title":"Examining the correlation between placental and serum placenta growth factor in preeclampsia","volume":"207","author":"Weed","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib250","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","article-title":"Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema","volume":"372","author":"Wells","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib251","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.ophtha.2016.02.022","article-title":"Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial","volume":"123","author":"Wells","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib252","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.preteyeres.2004.08.002","article-title":"Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration","volume":"24","author":"Wenzel","year":"2005","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib253","first-page":"849","article-title":"Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey","volume":"43","author":"Witmer","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib254","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1177\/002215540205000603","article-title":"Expression of vascular endothelial growth factor receptors 1, 2, and 3 in quiescent endothelia","volume":"50","author":"Witmer","year":"2002","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib255","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/path.969","article-title":"VEGFR-3 in adult angiogenesis","volume":"195","author":"Witmer","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib256","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1350-9462(02)00043-5","article-title":"Vascular endothelial growth factors and angiogenesis in eye disease","volume":"22","author":"Witmer","year":"2003","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib257","doi-asserted-by":"crossref","first-page":"43017","DOI":"10.1038\/srep43017","article-title":"Elevated expression of placental growth factor is associated with airway-wall vascular remodelling and thickening in smokers with asthma","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"issue":"Pt 3a","key":"10.1016\/j.preteyeres.2018.10.006_bib258","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/eye.1999.95","article-title":"Expression of placenta growth factor (PIGF) in ischaemic retinal diseases","volume":"13","author":"Yamashita","year":"1999","journal-title":"Eye (Lond)."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib259","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0165-0378(03)00082-2","article-title":"Evidence of a novel isoform of placenta growth factor (PlGF-4) expressed in human trophoblast and endothelial cells","volume":"60","author":"Yang","year":"2003","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib260","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/archopht.124.4.450","article-title":"Idiopathic macular telangiectasia","volume":"124","author":"Yannuzzi","year":"2006","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib261","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1073\/pnas.1109029108","article-title":"Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy","volume":"108","author":"Yao","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib262","doi-asserted-by":"crossref","first-page":"35172","DOI":"10.1074\/jbc.274.49.35172","article-title":"Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesis","volume":"274","author":"Yonekura","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib263","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12974-015-0368-7","article-title":"Neuroinflammatory responses in diabetic retinopathy","volume":"12","author":"Yu","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib264","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1042\/bst0311171","article-title":"VEGF signalling: integration and multi-tasking in endothelial cell biology","volume":"31","author":"Zachary","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib265","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.mvr.2004.07.004","article-title":"Expression of placenta growth factor is regulated by both VEGF and hyperglycaemia via VEGFR-2","volume":"68","author":"Zhao","year":"2004","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib266","doi-asserted-by":"crossref","first-page":"e512","DOI":"10.1111\/j.1755-3768.2012.02476.x","article-title":"Inhibition of ocular neovascularization by a novel peptide derived from human placenta growth factor-1","volume":"90","author":"Zheng","year":"2012","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib267","doi-asserted-by":"crossref","first-page":"e0146993","DOI":"10.1371\/journal.pone.0146993","article-title":"Placenta growth factor in eyes with neovascular glaucoma is decreased after intravitreal ranibizumab injection","volume":"11","author":"Zhou","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib268","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.18632\/oncotarget.13945","article-title":"Mesenchymal marker expression is elevated in Muller cells exposed to high glucose and in animal models of diabetic retinopathy","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.preteyeres.2018.10.006_bib269","doi-asserted-by":"crossref","first-page":"R505","DOI":"10.1152\/ajpregu.00137.2016","article-title":"Restoring placental growth factor-soluble fms-like tyrosine kinase-1 balance reverses vascular hyper-reactivity and hypertension in pregnancy","volume":"311","author":"Zhu","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.preteyeres.2018.10.006_bib270","doi-asserted-by":"crossref","first-page":"17958","DOI":"10.3390\/ijms140917958","article-title":"Inhibition of stromal PlGF suppresses the growth of prostate cancer xenografts","volume":"14","author":"Zins","year":"2013","journal-title":"Int. J. Mol. Sci."}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946218300600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946218300600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:28:50Z","timestamp":1761172130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946218300600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":271,"alternative-id":["S1350946218300600"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2018.10.006","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of placental growth factor (PlGF) and its receptor system in retinal vascular diseases","name":"articletitle","label":"Article Title"},{"value":"Progress in Retinal and Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preteyeres.2018.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}